Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2003
12/31/2003WO2003055916A3 Adiponectin fragments and conjugates
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003046129A3 Compositions for the derivation of germ cells from stem cells and methods of use thereof
12/31/2003WO2003045997A3 Fusion proteins containing tlp peptides
12/31/2003WO2003044166A3 METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER
12/31/2003WO2003040335A3 Engineering of leader peptides for the secretion of recombinant proteins in bacteria
12/31/2003WO2003040301A3 Cell cycle progression proteins
12/31/2003WO2003035722A8 Methods for controlling peptide solubility, chemically modified peptides, and stable solvent systems for producing same
12/31/2003WO2003033734A3 Diagnostic tests for the diagnosis of copper storage disease
12/31/2003WO2003033667A3 Use of mx gtpases in the prognosis and treatment of cancer
12/31/2003WO2003025174A3 Regulation of human mrp1-like protein
12/31/2003WO2003024316A3 Pore-forming agents for orthopedic cements
12/31/2003WO2003022996A3 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
12/31/2003WO2003022879B1 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis
12/31/2003WO2003010176A3 Protein-nucleic acid complexes
12/31/2003WO2003006492A3 Biologically active peptides
12/31/2003WO2002101232A3 Bace interacting proteins
12/31/2003WO2002097059B1 Chromosome-based platforms
12/31/2003WO2002088347A3 Aav helper plasmids for helper virus-free packaging and pseudo typification of aav vectors
12/31/2003WO2002079427A3 84226, a novel human cation transporter family member and uses thereof
12/31/2003WO2002077648A3 Pathogenic and commensal vaccine antigens
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002070004A3 Papillomavirus vaccines
12/31/2003WO2002067971A3 Use of endostatin in the treatment of ocular neovascularization
12/31/2003WO2002062946A9 Identification of novel ms4a gene family members expressed by hematopoietic cells
12/31/2003WO2002057469A3 Modulating developmental transitions in plants
12/31/2003WO2002053701A9 Epididymal lipocalin gene and uses thereof
12/31/2003WO2002050111A9 Isolated laminin 10
12/31/2003WO2002042444A3 Fungal gene cluster associated with pathogenesis
12/31/2003WO2002040718A3 Method to identify genes associated with chronic myelogenous leukemia
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2002038766A3 Human tumor necrosis factor receptor
12/31/2003WO2002031198A3 Cancer-linked genes as targets for chemotherapy
12/31/2003WO2001064710A8 Sulfated ccr5 peptides for hiv-1 infection
12/31/2003WO2000043409A3 Alpha-conotoxin peptides
12/31/2003CN1464907A Novel rice gene regulating salt stress tolerance
12/31/2003CN1464790A T cell receptor fusions and conjugates and methods of use thereof
12/31/2003CN1464068A Human brain tissue specificity molecular marker LRRC4
12/31/2003CN1464062A Expression vector pBVTB, its construction method and use in HCV vaccin research
12/31/2003CN1464061A Bean culture pattern schema regulating gene and use thereof
12/31/2003CN1464060A Bridsfoot trefoil pattern schema and anthotaxis structure regulating gene encoding protein and use thereof
12/31/2003CN1464059A Actinine fluorescent protein novel gene and its cloning, expression and use
12/31/2003CN1464058A Tumor-repressed fusion protein, its encoding gene and use thereof
12/31/2003CN1464057A Chemokine-like factor superfamily having skeletal muscle stimulating activity and immunoregulation function
12/31/2003CN1463984A Medicinal collagen material and its making process
12/31/2003CN1463983A Process for preparing albumin proserum using trans-gene animal
12/31/2003CN1463982A Human interleukin-17 receptor-like protein, its coding gene and use thereof
12/31/2003CN1463978A Carcinoma related gene and protein coded thereby
12/31/2003CN1463781A Process for extracting inner cell product using cytoclasis and double aqueous phase extraction technology
12/31/2003CN1132937C Nucleic acid markers for rice blast resistance genes and rice blast resistance genes isolated by the use of these markers
12/31/2003CN1132845C Improved method for obtaining isulin precursor having correctly-bonded cystine bond
12/31/2003CN1132844C Preparation method for engineering bateria for recombination of human leucocyte medium-18 and its product thereof
12/31/2003CN1132843C Simple ferredoxin separating process
12/31/2003CN1132842C Present invention relates to extraction of recombinant proteins produced by prokaryotic microorganism, especially by E. Coli
12/31/2003CN1132586C Immunomodulating compositions from bile
12/31/2003CA2829581A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
12/31/2003CA2740137A1 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
12/31/2003CA2493834A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
12/31/2003CA2491803A1 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders
12/31/2003CA2491196A1 Materials and methods for inductions of immune tolerance
12/31/2003CA2491070A1 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof
12/31/2003CA2491038A1 Dna sequence and recombinant production of the grass pollen allergen phl p4
12/31/2003CA2490746A1 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation
12/31/2003CA2490517A1 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives
12/31/2003CA2490449A1 Adjuvant-free peptide vaccine
12/31/2003CA2490399A1 Novel raag10 cell surface target and a family of antibodies recognizing that target
12/31/2003CA2490360A1 Pegylated factor vii glycoforms
12/31/2003CA2490195A1 A non-blended soybean oil with high oleic acid content
12/31/2003CA2490139A1 Novel bartonella antigen lysate extracts for use in elisa diagnostic
12/31/2003CA2490063A1 Methods of modulating cytokinin related processes in a plant using b3 domain proteins
12/31/2003CA2490004A1 Plastid division and related genes and proteins, and methods of use
12/31/2003CA2489930A1 Methods and means to promote gut absorption
12/31/2003CA2489907A1 Mhc class ii haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins
12/31/2003CA2489803A1 Compositions and methods for modulating lymphocyte activity
12/31/2003CA2489348A1 Apo-2 ligand/trail variants and uses thereof
12/31/2003CA2489057A1 Compositions and methods for apo-b48 and apo-b100 assay
12/31/2003CA2489052A1 Infectious cdna of an approved vaccine strain of measles virus, use for immunogenic compositions
12/31/2003CA2489024A1 Use of pp2a phosphatase modulators in the treatment of mental disorders
12/31/2003CA2488856A1 Packaged virus-like particles for use as adjuvants: method of preparation and use
12/31/2003CA2488848A1 Protein extraction from canola oil seed meal
12/31/2003CA2486490A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/30/2003US6670528 Transformed with DNA that encodes a protein linked to a promoter which can improve its resistance to dehydration, low temperature and salt; free from dwarfing
12/30/2003US6670526 Arabidopsis ESD4 gene and method to control flowering time
12/30/2003US6670467 Nucleotide sequences for tissue-independent or constitutive promoters for genes encoding actin-2, enolase, Gos-2 and L41
12/30/2003US6670466 Human endogenous retrovirus in breast cancer
12/30/2003US6670465 Mutations of the gene may cause a type of X-linked congenital stationary night blindness known as incomplete CSNB, and may also cause Aaland Island Eye Disease
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670463 Polynucleotides that encode carcinoma proteins or antibodies or immune system cells specific for such proteins.
12/30/2003US6670462 Nucleotide sequences coding polypeptide for use in the treatment of hepatitis and liver disorders
12/30/2003US6670460 Method of detection of alterations in MSH5
12/30/2003US6670452 Non-naturally occurring lipoprotein particle
12/30/2003US6670451 Netrins
12/30/2003US6670450 Polypeptide that inhibits the differentiation of myoblasts into myotubes as well as the transactivation function of p53, a transcription factor involved in tumor suppression.
12/30/2003US6670449 Hybrid molecules and their use for optically detecting changes in cellular microenvironments
12/30/2003US6670448 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier
12/30/2003US6670333 Providing exogenous antiangiogenic protein to endothelial cells associated with said tissue
12/30/2003US6670329 Isolated hybrid polypeptide
12/30/2003US6670328 Inflammatory diseases, xenograft or allograft rejection, asthma